123
Views
0
CrossRef citations to date
0
Altmetric
Review

Technological development of microemulsions with perspectives for pain treatment: a patent review

, , , , , & show all
Pages 691-702 | Received 16 Jul 2018, Accepted 30 Aug 2018, Published online: 14 Sep 2018

References

  • Danielsson I, Lindman B. The definition of microemulsion. Colloids Surf. 1981;3:391–392.
  • Hatzopoulos MH, Eastoe J, Dowding PJ, et al. Cylinder to sphere transition in reverse microemulsions: the effect of hydrotropes. J Colloid Interface Sci. 2013;392:304–310.
  • Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45:89–121.
  • Mitsou E, Tavantzis G, Sotiroudis G, et al. Food grade water-in-oil microemulsions as replacement of oil phaseto help process and stabilization of whipped cream. Colloids Surf A Physicochem Eng Asp. 2016;510:69–76.
  • Volpe V, Nascimento DS, Insausti M, et al. Octyl p-methoxycinnamate loaded microemulsion based on ocimum basilicum essential oil. Characterization and analytical studies for potential cosmetic applications. Colloids Surf Physicochem Eng Asp. 2018;546:285–292.
  • Damasceno BPGL, Silva JÁ, Oliveira EE, et al. Microemulsão: um promissor carreador paramoléculas insolúveis. Rev ciênc farm básica apl. 2011;32(1):9–18.
  • Callender SP, Mathews JA, Kobernyk K, et al. Microemulsion utility in pharmaceuticals: implications for multi-drug delivery. Int J Pharm. 2017;526:425–442.
  • Kaur G, Mehta SK. Developments of polysorbate (Tween) based microemulsions: preclinical drug delivery, toxicity and antimicrobial applications. Int J Pharm. 2017;529:134–160.
  • Sindhu P, Kumara S, Iqbal B, et al. Duloxetine loaded-microemulsion system to improve behavioral activities by upregulating serotonin and norepinephrine in brain for the treatment of depression. J Psychiatr Res. 2018;99:83–95.
  • Li Y, Song J, Tian N, et al. Improving oral bioavailability of metformin hydrochloride using water-in-oil microemulsions and analysis of phase behavior after dilution. Int J Pharm. 2014;473:316–325.
  • Ren X, Svirskis D, Alany RG, et al. In-situ phase transition from microemulsion to liquid crystal with the potential of prolonged parenteral drug delivery. Int J Pharm. 2012;431:130–137.
  • Sharma G, Dhankar G, Thakur K, et al. Benzyl benzoate-loaded microemulsion for topical applications: enhanced dermatokinetic profile and better delivery promises. AAPS Pharm Sci Tech. 2016;17:1221–1231.
  • Carvalho ALM, Silva JA, Lira AAM, et al. Evaluation of microemulsion and lamellar liquid crystalline systems for transdermal zidovudine delivery. J Pharm Sci. 2016;105:188–2193.
  • Alkrad J, Talhouni AA. In vivo and in vitro study of transdermal application of diclofenac sodium using nonionic microemulsions as colloidal drug delivery systems. J Drug Deliv Sci Technol. 2018;43(27–33):2018.
  • Mulla JAS, Mabrouk M, Choonara YE, et al. Development of respirable rifampicin-loaded nano-lipomer composites by microemulsion-spray drying for pulmonary delivery. J Drug Deliv Sci Technol. 2017;41:13–19.
  • Lidich N, Aserin A, Garti N. Structural characteristics of oil-poor dilutable fish oil omega-3 microemulsions for ophthalmic applications. J Colloid Interface Sci. 2016;463:83–92.
  • Zhang J, Michniak-Kohn B. Investigation of microemulsion and microemulsion gel formulations for dermal delivery of clotrimazole. Int J Pharm. 2018;536:345–352.
  • Fonseca-Santos B, Chorilli M. An overview of polymeric dosage forms in buccal drug delivery: state of art, design of formulations and their in vivo performance evaluation. Mater Sci Eng C. 2018;86:129–143.
  • Bachhav YG, Patravale VB. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. Int J Pharm. 2009;365:175–179.
  • Sintov AC. Transdermal delivery of curcumin via microemulsion. Int J Pharm. 2015;481:97–103.
  • Hathout RM, Nasr M. Transdermal delivery of betahistine hydrochloride using microemulsions: physical characterization, biophysical assessment, confocal imaging and permeation studies. Colloids Surf B. 2013;110:254–260.
  • Moghimipour E, Salimi A, Eftekhari S. Design and characterization of microemulsion systems for naproxen. Adv Pharm Bull. 2013;3(1):63–71.
  • Trivedi H, Thakur R, Ray S, et al. Design and evaluation of piroxicam microemulsion. Int J Pharm Res Scholars. 2012;1:166–177.
  • Dehghani F, Farhadian F, Golmohammadzadeh S, et al. Preparation, characterization and in-vivo evaluation of microemulsions containing tamoxifen citrate anti-cancer drug. Eur J Pharm Sci. 2017;96:479–489.
  • Zhang YT, Li Z, Zhang K, et al. Co-delivery of evodiamine and rutaecarpine in a microemulsion-based hyaluronic acid hydrogel for enhanced analgesic effects on mouse pain models. Int J Pharm. 2017;528:100–106.
  • Maestrelli F, Bragagni M, Mura P. Advanced formulations for improving therapies with anti-inflammatory or anaesthetic drugs: A review. J Drug Deliv Sci Technol. 2016;32:192–205.
  • Pineros I, Slowing K, Serrano D, et al. Analgesic and anti-inflammatory controlled-released injectable microemulsion: pseudo-ternary phase diagrams, in vitro, ex vivo and in vivo evaluation. Eur J Pharm Sci. 2017;101:220–227.
  • Ma Q, Davidson PM, Zhong Q. Antimicrobial properties of microemulsions formulated with essential oils, soybean oil, and Tween 80. Int J Food Microbiol. 2016;226:20–25.
  • Ronchetti S, Migliorati G, Delfino DV. Association of inflammatory mediators with pain perception. Biomed Pharmacother. 2017;96:1445–1452.
  • Fabregat-Cid G, Asensio-Samper JM, Villanueva-Pérez V, et al. Manejo perioperatorio del dolor en el paciente en tratamiento crónico con opiáceos. Rev Esp Anestesiol Reanim. 2011;58:25–33.
  • Dale R, Stacey B. Multimodal treatment of chronic pain. Med Clin North Am. 2016;100:55–64.
  • Hernández-Porras BC, Plancarte-Sánchez R, Alarcón-Barrios S, et al. Síndrome doloroso regional complejo: revisión. Cir Cir. 2017;85:366–374.
  • Já S, Santana DP, Bedor DGC, et al. In vitro release and permeation of a diclofenac diethylamine from microemulsion gel-like. Quim Nova. 2009;32(6):1389–1393.
  • Larm MG, Harding R, Johnston M, et al. Microemulsion e sub-micron emulsion process e compositions. US20150258023. 2015.
  • Fanun M. Microemulsions as delivery systems. Curr Opin Colloid Interface Sci. 2012;17:306–313.
  • Froelich A, Osmałek T, Snela A, et al. Novel microemulsion-based gels for topical delivery of indomethacin: formulation, physicochemical properties and in vitro drug release studies. J Colloid Interface Sci. 2017;507:323–336.
  • Premarathne EPN, Karunaratne DN, Perera ADLC. Controlled release of diclofenac sodium in glycolipid incorporated micro emulsions. Int J Pharm. 2016;511:890–898.
  • Liu CH, Chang FY, Hung DK. Terpene microemulsions for transdermal curcumin delivery: effects of terpenes and cosurfactants. Colloids Surf B Biointerfaces. 2011;82:63–70.
  • Larm MG, Harding R. Microemulsion process and composition. US20060057168. 2006.
  • Salamone JC, Chen X, Salamone AB, et al. Delivery of biologically-active agents using volatile, hydrophobic solvents. US20140127320. 2014.
  • Füredi P, Pápay Z, Kovács K, et al. Development and characterization of the voriconazole loaded lipid-based nanoparticles. J Pharm Biomed Anal. 2017;132:184–189.
  • Sánchez-López E, Espina M, Doktorovova S, et al. Lipid nanoparticles (SLN, NLC): overcoming the anatomical and physiological barriers of the eye – part II - ocular drug-loaded lipid nanoparticles. Eur J Pharm Biopharm. 2017;110:58–69.
  • Magdassi S, Netivi H, Goshen K. Organic nanoparticles obtained from microemulsions by solvent evaporation. US20110021592 (2011).
  • Salabat A, Nabiyouni G, Far MR. Effect of platinum precursor on the nanoparticle size synthesized in microemulsion system. J Exp Nanosci. 2011;6:305–310.
  • Salabat A, Soleimani S. Ultrasonic irradiation and solvent effects on destabilization of the colloidal suspensions of platinum nanoparticles. Particuology. 2014;17:145–148.
  • Soleimani S, Salabat A, Tabor RF. Effect of surfactant type on platinum nanoparticles size of the synthesized Pt/-Al2O3 catalyst by microemulsion method. J Colloid Interface Sci. 2014;426:287–292.
  • Tianimoghadama S, Salabat A. A microemulsion method for preparation of thiol-functionalized gold nanoparticles. Particuology. 2018;37:33–36.
  • Wang Y, Zhang X, Wang A, et al. Synthesis of ZnO nanoparticles from microemulsions in a flow type microreactor. Chem Eng J. 2014;235:191–197.
  • Tagavifar M, Jang SH, Chang L, et al. Controlling the composition, phase volume, and viscosity of microemulsions with cosolvent. Fuel. 2018;211:214–222.
  • Chiappisi L, Noirez L, Gradzielski M. A journey through the phase diagram of a pharmaceutically relevant microemulsion system. J Colloid Interface Sci. 2016;473:52–59.
  • Fischer V, Marcus J, Touraud D, et al. Toward surfactant-free and water-free microemulsions. J Colloid Interface Sci. 2015;453:186–193.
  • Lucia A, Argudo PG, Guzmán E, et al. Formation of surfactant free microemulsions in the ternary system water/eugenol/ethanol. Colloids Surf A Physicochem Eng Asp. 2017;521:133–140.
  • Hou W, Xu J. Surfactant-free microemulsions. Curr Opin Colloid Interface Sci. 2016;25:67–74.
  • Seok S, Lee S, Park E. Formulation of a microemulsion-based hydrogel containing celecoxib. J Drug Deliv Sci Technol. 2018;43:409–414.
  • Lopes LB, Vandewall H, Li HT, et al. Topical delivery of lycopene using microemulsions: enhanced skin penetration and tissue antioxidant activity. J Pharm Sci. 2010;99:1346–1357.
  • Wang X, Xue M, Gu J, et al. Transdermal microemulsion drug delivery system for impairing male reproductive toxicity and enhancing efficacy of tripterygium wilfordii hook F. Fitoterapia. 2012;83:690–698.
  • Wang A, Chen L, Xu F, et al. Phase behavior of epoxidized soybean oil-based ionic liquid microemulsions: effects of ionic liquids, surfactants, and co-surfactants. Colloids Surf A Physicochem Eng Asp. 2015;481:500–505.
  • Sharifi-Rad J, Sureda A, Tenore GC, et al. Biological activities of essential oils: from plant chemoecology to traditional healing systems. Molecules. 2017;22:1–55.
  • Kejlová K, Jírová D, Bendová H, et al. Phototoxicity of essential oils intended for cosmetic use. Toxicol In Vitro. 2010;24:2084–2089.
  • Khayyat SA, Roselin LS. Recent progress in photochemical reaction on main components of some essential oils. J Saudi Chem Soc. 2018. In press.
  • El-Zaeddi H, Martínez-Tomé J, Calín-Sánchez A, et al. Volatile composition of essential oils from different aromatic herbs grown in mediterranean regions of Spain. Foods. 2016;5:41–54.
  • Sanggu K. Sugar-based surfactant microemulsions containing essential oils for cosmetic and pharmaceutical use. US20130237613. 2013.
  • Maciel MAM, Medeiros ML, Araújo-Filho I, et al. Formulados a base de óleo de copaíba biodisponibilizados para uso oral e tópico associado com aplicações terapêuticas na analgesia, inflamação e cicatrização. BR1020170148009. 2017.
  • Lisheng W, Hongying S, Wenqiang B, et al. Tripterygium wilfordii-caulis sinomenii microemulsion gel and preparation method thereof. CN104306447. 2015.
  • Costa M, Ferreira K, Botosso P, et al. Growth analysis of five leguminosae native tree species from a seasonal semidecidual lowland forest in Brazil. Dendrochronologia. 2015;36:23–32.
  • Gonçalves ES, Silva JR, Gomes CL, et al. Effects of the oral treatment with Copaifera multijuga oil on reproductive performance of male wistar rats. Rev Bras Farmacogn. 2014;24(3):355–362.
  • Gomes NM, Rezende CM, Fontes SP, et al. Characterization of the antinociceptive and anti-inflammatory activities of fractions obtained from Copaifera multijuga Hayne. J Ethnopharmacol. 2010;128:177–183.
  • Costa JC, Valladão GMR, Pala G, et al. Copaifera duckei oleoresin as a novel alternative for treatment of monogenean infections in pacu Piaractus mesopotamicus. Aquaculture. 2017;471:72–79.
  • Santos AO, Costa MA, Ueda-Nakamura T, et al. Leishmania amazonensis: effects of oral treatment with copaiba oil in mice. Exp Parasitol. 2011;129:145–151.
  • Saraiva ME, Ulisses AVRA, Ribeiro DA, et al. Plant species as a therapeutic resource in areas of the savanna in the state of Pernambuco, Northeast Brazil. J Ethnopharmacol. 2015;171:141–153.
  • Gelmini F, Beretta G, Anselmi C, et al. GC–MS profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii desf. and a preliminary in vivo evaluation of its antipsoriatic effect. Int J Pharm. 2013;440:170–178.
  • Costa-Machado ARM, Bastos JK, Freitas LAP. Dynamic maceration of Copaifera langsdorffii leaves: A technological study using fractional factorial design. Braz J Pharmacog. 2013;23:79–85.
  • Santos HM, Oliveira DF, Carvalho DA, et al. Evaluation of native and exotic Brazilian plants for anticancer activity. J Nat Med. 2010;64:231–238.
  • Batista AG, Ferrari AS, Cunha DC, et al. Polyphenols, antioxidants, and antimutagenic effects of Copaifera langsdorffii fruit. Food Chem. 2016;197:1153–1159.
  • Zhang W, Li F, Gao W. Tripterygium wilfordii inhibiting angiogenesis for Rheumatoid arthritis treatment. J Natl Med Assoc. 2017;109:142–148.
  • Wang X, Zu Y, Huang L, et al. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: a meta-analysis. Life Sci. 2017;171:45–50.
  • Wang X, Xue M, Gu J, et al. Transdermal microemulsion drug delivery system for impairing male reproductive toxicity and enhancing efficacy of tripterygium wilfordii hook. Fitoterapia. 2012;83:690–698.
  • Rivera-Rangela RD, González-Muñoza MP, Avila-Rodrigueza M, et al. Green synthesis of silver nanoparticles in oil-in-water microemulsion and nano-emulsion using geranium leaf aqueous extract as a reducing agent. Colloids Surf A. 2018;536:60–67.
  • Biruss B, Kahlig H, Valenta C. Evaluation of an eucalyptus oil containing topical drug delivery system for selected steroid hormones. Int J Pharm. 2007;328:142–151.
  • Alles S, Smith PA. Etiology and pharmacology of neuropathic pain. Pharmacol Rev. 2018;70(2):315–347.
  • Hatch MN, Cushing TR, Carlson GD, et al. Neuropathic pain and SCI: identification and treatment strategies in the 21st century. J Neurol Sci. 2018;384:75–83.
  • Badri W, Miladi K, Nazari Q, et al. Encapsulation of NSAIDs for inflammation management: overview, progress, challenges and prospects. Int J Pharm. 2016;515:757–773.
  • Al-Tabakha M. Encapsulation of ketoprofen for controlled drug release. Eur J Pharm Biopharm. 2007;66:48–54.
  • Laffleur F, Hintzen F, Shahnaz G, et al. Development and in vitro evaluation of slippery nanoparticles for enhanced diffusion through native mucus. Nanomedicine. 2014;9:387–396.
  • Liuzzi R, Carciati A, Guido S, et al. Transport efficiency in transdermal drug delivery: what is the role of fluid microstructure? Colloids Surf B Biointerfaces. 2016;139:294–30.
  • Pyo WY, Min CS Transdermal patch for nonsteroidal antiinflammatory drug(s). GB2362825 (2002).
  • Chandra A, Sharma PK. Microemulsion. IN274/DEL/2008. 2008.
  • Lichtenberger LM, Shiqiang T. Oil-based nsaid compositions and methods for making and using same. US20100173876. 2010.
  • Jose FF. O papel dos anti-inflamatórios não hormonais no tratamento da dor musculoesquelética. J Bras Med. 2014;102:5.
  • Grim TW, Ghosh S, Hsu KL, et al. Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models. Pharmacol Biochem Behav. 2014;124:405–411.
  • Liu L, Komatsu T, Zor F, et al. (128): sustained analgesic and anti-inflammatory efficacy of single dose COX-2 inhibiting nonomedicine in a murine inflammatory pain model. J Pain. 2018;19:s9.
  • Dogrul A, Seyrek M, Akgul E, et al. Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT(7) receptors. Eur J Pharmacol. 2012;677:93–101.
  • Roca-Vinardell A, Berrocoso E, Llorca-Torralba M, et al. Involvement of 5-HT1A/1B receptors in the antinociceptive effect of paracetamol in the rat formalin test. Neurobiol Pain. 2018;3:15–21.
  • St-Jacques B, Ma W. Peripheral prostaglandin E2 prolongs the sensitization of nociceptive dorsal root ganglion neurons possibly by facilitating the synthesis and anterograde axonal trafficking of EP4 receptors. Exp Neurol. 2014;261:354–366.
  • Fusaro MGCO, Silva AP, Araldi D, et al. P2X3 and P2X2/3 receptors mediate mechanical hyperalgesia induced by bradykinin, but not by pro-inflammatory cytokines, PGE2 or dopamine. Eur J Pharmacol. 2010;649:177–182.
  • Zakeri A, Yazdi FG. Toll-like receptor-mediated involvement of innate immune cells in asthma disease. Biochim Biophys. 2017;1861:3270–3277.
  • Cioato SG, Medeiros LF, Marques-Filho PR, et al. Long-lasting effect of transcranial direct current stimulation in the reversal of hyperalgesia and cytokine alterations induced by the neuropathic pain model. Brain Stimul. 2016;9:209–217.
  • Rabelo TK, Guimarães AG, Oliveira MA, et.al. Shikimic acid inhibits LPS-induced cellular pro-inflammatory cytokines and attenuates mechanical hyperalgesia in mice. Int Immunopharmacol. 2016;39:97–105.
  • Gruber-Schoffnegger D, Drdla-Schutting R, Honigsperger C, et al. Induction of thermal hyperalgesia and synaptic long-term potentiation in the spinal cord lamina I by TNF-alpha and IL-1beta is mediated by glial cells. J Neurosci. 2013;33:6540–6551.
  • Sun C, Zhang J, Chen L, et al. IL-17 contributed to the neuropathic pain following peripheral nerve injury by promoting astrocyte proliferation and secretion of proinflammatory cytokines. Mol Med Rep. 2017;15:89–96.
  • Zhang H, Li F, Li WW, et al. The inflammasome as a target for pain therapy. Br J Anaesth. 2016;117:693–707.
  • Ferrari LF, Lotufo CM, Araldi D, et al. Inflammatory sensitization of nociceptors depends on activation of NMDA receptors in DRG satellite cells. Proc Natl Acad Sci. 2014;111:18363–18368.
  • Niesters M, Dahan A. Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain. Expert Opin Drug Metab Toxicol. 2012;8:1409–1417.
  • Radwani H, Roca-Lapirot O, Aby F, et al. [EXPRESS] group I metabotropic glutamate receptor plasticity after peripheral inflammation alters nociceptive transmission in the dorsal of the spinal cord in adult rats. Mol Pain. 2017;13:1–13.
  • Kim MJ, Park YH, Yang KY, et al. Participation of central GABAA receptors in the trigeminal processing of mechanical allodynia in rats. Korean J Physiol Pharmacol. 2017;21:65–74.
  • Piccinelli AC, Morato PN, Barbosa MS, et al. Limonene reduces hyperalgesia induced by gp120 and cytokines by modulation of IL-1 β and protein expression in spinal cord of mice. Life Sci. 2017;174:28–34.
  • Khan J, Noboru N, Imamura Y, et al. Effect of pregabalin and diclofenac on tactile allodynia, mechanical hyperalgesia and pro inflammatory cytokine levels (IL-6, IL-1β) induced by chronic constriction injury of the infraorbital nerve in rats. Cytokine. 2018;104:124–129.
  • Myers J, Wielage RC, Han B, et al. The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis. BMC Musculoskelet Disord. 2014;15:76.
  • Fujita I, Okumura T, Sakakibara A, et al. Involvement of inflammation in severe post-operative pain demonstrated by pre-surgical and post-surgical treatment with piroxicam and ketorolac, J. Pharm Pharmacol. 2012;64(5):747–755.
  • Gupta A, Bah M. NSAIDs in the treatment of postoperative pain. Curr Pain Headache. 2016;20:62.
  • Miranda HF, Sierralta F, Aranda N, et al. Pharmacological profile of dexketoprofen in orofacial pain. Pharmacol Rep. 2016;68:1111–1114.
  • Dym H, Bowler D, Zeidan J. Pharmacologic treatment for temporomandibular disorders. Dent Clin North Am. 2016;60:367–379.
  • Abbas AM, Ali SS, Salem MN, et al. Effect of oral ketoprofen on pain perception during copper IUD insertion among parous women: A randomized double-blind controlled trial. Middle East Fertil Soc J. 2018. In Press.
  • Serinken M, Eken C, Tunay K, et al. Ketoprofen gel improves low back pain in addition to IV dexketoprofen: a randomized placebo-controlled trial. Am J Emerg Med. 2016;34:1458–1461.
  • Jaramillo-Morales OA, Espinosa-Juárez JV, García-Martínez BA, et al. Ketoprofen and antinociception in hypo-oestrogenic wistar rats fed on a high sucrose diet. Eur J Pharmacol. 2016;788:168–175.
  • Ibrahim MA, Abdelzaher WY, Rofaeil RR, et al. Efficacy and safety of combined low doses of either diclofenac or celecoxib with gabapentin versus their single high dose in treatment of neuropathic pain in rats. Biomed Pharmacother. 2018;100:267–274.
  • Lima TC, Bagordakis E, Falci SGM, et al. Pre-emptive effect of dexamethasone and diclofenac sodium associated with codeine on pain, swelling, and trismus after third molar surgery: a split-mouth, randomized, triple-blind, controlled clinical trial. J Oral Maxillofac Surg. 2018;76:60–66.
  • Lichtenberger LM. Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity. US20150011507. 2015.
  • Campoverde KC, Giner-Munoz MT, Valdez LM, et al. Hypersensitivity reactions to non-steroidal anti-inflammatory drugs and tolerance to alternative drugs. An Pediatr (Barc). 2016;84:148–153.
  • Bjarnason I, Scarpignato C, Holmgren E, et al. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterol. 2018;154:500–514.
  • Velasco-Zamora JA, Gómez-Reyes E, Uscanga L. Are the clinical guideline recommendations on gastroprotection being followed? A review in patients taking nonsteroidal anti-inflammatory drugs. Rev Gastroenterol Mex. 2016;81:121–125.
  • Ramírez FB, Núñez CG, Mas MT, et al. Criterios para la erradicación de Helicobacter pylori. FMC. 2018;25:43–53.
  • Raut S, Bhadoriya SS, Uplanchiwar V, et al. Lecithin organogel: a unique micellar system for the delivery of bioactive agents in the treatment of skin aging. Acta Pharm Sin B. 2012;2(1):8–15.
  • Ehehalt R, Braun A, Karner M, et al. Phosphatidylcholine as a constituent in the colonic mucosal barrier—physiological and clinical relevance. Biochim Biophys Acta. 2010;1801:983–993.
  • Olson A, Diebel LN, Liberati DM. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin. J Trauma Acute Care Surg. 2014;77:570–575.
  • Moran-Valero MI, Ruiz-Henestrosa VMP, Pilosof AR. Synergistic performance of lecithin and glycerol monostearate in oil/water emulsions. Colloids Surf B Biointerfaces. 2017;151:68–75.
  • Wang S, Shi Y, Tu Z, et al. Influence of soy lecithin concentration on the physical properties of whey protein isolate-stabilized emulsion and microcapsule formation. J Food Eng. 2017;207:73–80.
  • Riehm DA, Rokke DJ, Paul PG, et al. Dispersion of oil into water using lecithin-Tween 80 blends: the role of spontaneous emulsification. J Colloid Interface Sci. 2017;487:52–59.
  • Nissim G, Aserin A, Kogan A. Microemulsion comprising carbamazepine having solubility. WO/2006/061827. 2006.
  • Lu DR, Shawer M. Artificial lipoprotein carrier system for bioactive materials. US20040234588. 2004.
  • Ekwuribe NN, Ramaswamy M, Radhakrishnan B, et al. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin. US6191105. 2001.
  • Lin YH, Tsai MJ, Fang YP, et al. Microemulsion formulation design and evaluation for hydrophobic compound: catechin topical application. Colloids Surf B Biointerfaces. 2018;161:121–128.
  • Petchsangsai M, Rojanarata T, Opanasopit P, et al. The combination of microneedles with electroporation and sonophoresis to enhance hydrophilic macromolecule skin penetration. Biol Pharm Bull. 2014;37(8):1373–1382.
  • Azeem A, Khan ZI, Aqil M, et al. Microemulsions as a surrogate carrier for dermal drug delivery. Drug Dev Ind Pharm. 2009;35:535–547.
  • Kupper S, Kłosowska-Chomiczewska I, Szumała P. Collagen and hyaluronic acid hydrogel in water-in-oil microemulsion delivery systems. Carbohydr Polym. 2017;175:347–354.
  • Todosijevi MN, Savi MM, Batini BB, et al. Biocompatible microemulsions of a model NSAID for skin delivery: A decisive role of surfactants in skin penetration/irritation profiles and pharmacokinetic performance. Int J Pharm. 2015;496:931–941.
  • Barnikol-Keuten D, Gulik D. Medicament and System for the Percutaneous Preparation of Medicaments. CH20130315969. 2013.
  • Xu J, Liu X, Pang M. Numerical and experimental studies on transport properties of powder ejector based on double venturi effect. Vacuum. 2016;134:92–98.
  • Ji D, Zhang M, Xu T, et al. Experimental and numerical studies of the jet tube based on venture effect. Vacuum. 2015;111:25–31.
  • Carlucci MJ, Damonte EB, Scolaro LA. Virus driven evolution: A probable explanation for “Similia Similibus Curantur” philosophy. Infect Genet Evol. 2011;11:798–802.
  • Teixeira MZ. New homeopathic medicines: use of modern drugs according to the principle of similitude. Homeopathy. 2011;100:244–252.
  • Warner KS, Zhang J. Gelled emulsion and microemulsion formulations for dermal drug delivery. US20050266085. 2005.
  • Schwarz J, Klang V, Hoppel M, et al. Natural microemulsions: formulation design and skin interaction. Eur J Pharm Biopharm. 2012;81:557–562.
  • Bardhan S, Kundu K, Saha SK, et al. Physicochemical studies of mixed surfactant microemulsions with isopropyl myristate as oil. J Colloid Interface Sci. 2013;402:180–189.
  • Hathout RM, Woodman TJ, Mansour S, et al. Microemulsion formulations for the transdermal delivery of testosterone. Eur J Pharm Sci. 2010;40(3):188–196.
  • Yehia R, Hathout RM, Attia DA, et al. Antitumor efficacy of an integrated methyl dihydrojasmonate transdermal microemulsion system for breast cancer cells: in vitro and in vivo studies. Colloids Surf B Biointerfaces. 2017;155:512–521.
  • Casalengua MLT, Holgado Js DÍAZMBH, Peña MPA. Uso de opioides en pacientes con dolor crónico. Terapéutica em APS. 2016;23:607–616.
  • Rodriguez-Aller M, Guillarme D, Veuthey J, et al. Strategies for formulating and delivering poorly water-soluble drugs. J Drug Deliv Sci Technol. 2015;30:342–351.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.